Medicamen Biotech Ltd Annual Report for FY 2025-26 Filed

Medicamen Biotech Ltd has submitted its Integrated Annual Report for the Financial Year 2025-26, as per SEBI regulations. The report includes the notice for the 16th Annual General Meeting (AGM) scheduled for September 29, 2026. The Annual Report and AGM notice are also available on the company's website, www.eightyjewels.in. The filing details the company's performance, vision, mission, and corporate structure, including its board of directors and key managerial personnel. The report covers financial statements like the Balance Sheet, Profit and Loss Statement, and Cash Flow Statement, along with management discussions and auditor's reports.